ASSIGNMENT OF BL-1040 PROJECT
EXHIBIT
10.7
ASSIGNMENT OF BL-1040
PROJECT
THIS
ASSIGNMENT (the "Assignment")
is made effective as of January 1, 2009, by and between BioLine
Innovations Jerusalem, Limited Partnership ("Assignor") and BioLineRx,
Ltd. ("Assignee").
WHEREAS,
Assignor entered into that certain License Agreement dated as of January
10, 2005 with B.G. Negev Technologies and Applications, Ltd. (the "License Agreement'); and
WHEREAS,
Assignor desires to assign the License Agreement to Assignee pursuant to Section
14.10 thereof, and Assignee desires to accept such assignment;
NOW,
THEREFORE, the parties hereto hereby agree as follows:
1.
Assignor hereby assigns the License Agreement, and all of Assignor's rights,
obligations
and interests thereunder to Assignee.
2.
Assignee hereby accepts the foregoing assignment and agrees to be bound by
the terms
of the License Agreement.
3. This
Assignment shall be construed in accordance with the laws of the State
of Israel.
IN
WITNESS WHEREOF, the parties hereto have caused this Assignment to be duly
executed as of the date first above written.
|
ASSIGNOR
|
ASSIGNEE
|
|
|
BioLine
Innovations Jerusalem, LP
|
BioLineRx,
Ltd.
|
|
|
By
It s General Partner
|
||
|
BioLine
Innovations Jerusalem, Ltd.
|
||
|
/s/ ▇▇▇▇
▇▇▇▇▇▇▇
|
/s/ ▇▇▇▇
▇▇▇▇▇▇▇
|
|
|
Date: 21.4.09
|
Date: 21.4.09
|